By Duke University - Science Daily - Biomedical engineers at Duke University have developed a new technique to better understand and test treatments for a group of extremely rare muscle disorders called dysferlinopathy or limb girdle muscular dystrophies 2B (LGMD2B)....

by Hannah Thomasy, PhD - The Scientist - Yejing Ge explores the behavior of skin-resident stem cells in wound repair, cancer, and aging. In 1986, Harold Dvorak, a pathologist at Harvard Medical School, popularized the idea of cancer as a wound that does not heal. In...

By Gret Harrison - USC Viterbi - New research harnesses machine learning and imaging to give unprecedented insight into stem cell behavior that could enable future lifesaving therapies. Stem cells are like the emergency tool kit of the human body. They have the unique...

By Hannah Thomasy, PhD - Exploring Drug Discovery and Development News - The black rat rested calmly in a clear tube, its nose twitching gently as it sniffed the air. Its eyes followed the parade of vertical black and white bars scrolling from left to right across a...

Dr. Omer Awan MD MPH CIIP - Forbes - Recently, a 12-year-old boy became the first patient with sickle cell disease to begin commercially approved gene therapy that could potentially cure the condition. Read the article - Click Here

by Ian Haydon, University of Washington School of Medicine - Phys.org - Using computer-designed proteins, researchers have now shown they are able to direct human stem cells to form new blood vessels in the lab. This milestone in regenerative medicine offers new hope...

By Laurie Kaiser - University of Buffalo - When the myelin sheath that surrounds nerve fibers in the brain and spinal cord becomes damaged, a number of debilitating conditions can result that limit mobility, inhibit independence and reduce life expectancy. Multiple...

by Isabella Ciccone, MPH - Nueurology Live - Recently, the FDA granted regenerative medicine advanced therapy (RMAT) designation to uniQure’s investigational Huntington disease (HD) gene therapy AMT-130 based on interim data from a phase 1/2 trial (NCT04120493) and a...

By Ryan Browne - CNBC - PARIS, France — French beauty and cosmetics giant L'Oreal is working on a form of synthetically produced skin that it says will one day be able to "feel" like we do. At the Viva Technology conference in Paris last week, L'Oreal showed off...

by Letisia Marquez - City of Hope - Treating prostate cancer with immunotherapy is currently difficult to do. But preliminary results from a first in-human phase 1 trial using a chimeric antigen receptor (CAR) T cell therapy developed by researchers from City of Hope®...

by Alejandra Manjarrez, PhD - Drug Discovery News - Researchers harvest stem cells from patients who have recently had a heart attack and use them to trigger regeneration of their cardiac muscle. For many people, surviving a heart attack is just the beginning. Within...

by YUTA MAEDA - Nikkei - TOKYO -- A Japanese startup is poised to become the first in the world to seek government approval for a therapy derived from human induced pluripotent stem (iPS) cells, Nikkei has learned, with a less invasive alternative for treating heart...